Fezolinetant significantly reduces vasomotor symptoms in post-menopausal women
1. Fezolinetant 30 mg and 45 mg significantly reduced the frequency and severity of vasomotor symptoms compared to placebo. 2. ...
1. Fezolinetant 30 mg and 45 mg significantly reduced the frequency and severity of vasomotor symptoms compared to placebo. 2. ...
1. Linzagolix (100 mg and 200 mg) significantly reduced heavy menstrual bleeding in women with uterine fibroids compared to placebo. ...
1. Relugolix combination therapy significantly reduced endometriosis-associated dysmenorrhea and non-menstrual pelvic pain compared to placebo. 2. Adverse events were similar ...
1. The use of long-term transdermal estrogen for castration therapy for prostate cancer showed no difference in cardiovascular events versus ...
1. In this pair of identical phase 3 trials involving premenopausal women with uterine fibroids, both elagolix with and without ...
1. In this pair of identical phase 3 trials involving premenopausal women with uterine fibroids, both elagolix with and without ...
Breast cancer is the most common cancer seen in females, though it is rare in males. Transgender individuals experience incongruence ...
Association between incidence exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion Previous studies have shown that benzodiazepine ...
Image: PD 1. From a model of simulated health outcomes based on the Women’s Health Initiative (WHI) estrogen plus progestin ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.